Future-proof EU pharma innovation needs regulatory testing zones

20-02-2026

EURACTIV - As the EU Pharma Package enters implementation, Roche Belgium argues that reform alone will not secure Europe's competitiveness unless regulatory frameworks evolve to accommodate new technologies. Read more

Marie-José Borst, general manager, Roche Pharmaceuticals Belgium and Luxembourg, and Isabelle Decker, general manager, Roche Diagnostics Belgium



     

    Share